Clinical Trial

TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical study is to learn more about the effects of TAVR-prosthesis positioning on hemodynamics and the coronary arteries. The main questions it aims to answer are: 1. Does the cardiac magnetic resonance imaging and the echocardiography imaging provide an equivalent alternative to the computer tomography which is the state of the art in evaluating commissural alignment? 2. What effect does the position of the valve on the annular level have, especially its symmetrical and commissural position, on valvular and aortic blood flow characteristics? 3. What is the influence of symmetrical position and the presence of a commissural alignment on the coronary flow after transcatheter aortic valve replacement?
Trial Details
NCT Number NCT06896227
Lead Sponsor Heinrich-Heine University, Duesseldorf
Conditions Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Implantation, Commissural Alignment, Commissural Misalignment, Symmetry, Prothesis Positioning, Prosthesis Durability, Aortic Valve Stenosis +1 more
Enrollment 100 participants
Start Date 2024-10-22
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-26